Finally, RT–qPCR analysis showed that WNT3 had significantly higher expression in CD34+ cells from CML patients in both chronic phase and blast crisis than in NBM CD34+ cells (Fig. 3E). Here, WNT3 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.